Patents by Inventor Danielle DeVoney

Danielle DeVoney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating animals to enhance natural killer lymphocyte function
    Patent number: 5914346
    Abstract: A method of enhancing the activity of natural killer lymphocytes and a method for increasing the basal level of natural killer activity in an animal include the step of administering orally or parenterally to said animal a safe amount of CLA, said amount being effective to enhance the activity of killer lymphocytes or to enhance the basal activity of killer lymphocytes in the animal.
    Type: Grant
    Filed: November 4, 1997
    Date of Patent: June 22, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Mark E. Cook, Sohee Kim, Michael W. Pariza, Danielle DeVoney
  • Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
    Patent number: 5827885
    Abstract: Methods of treating animals to maintain or elevate CD-4 and CD-8 cell levels and to prevent or alleviate the adverse effects on the animal caused by the production or exogenous administration of tumor necrosis factor (TNF) or by a virus consist of administering to the animal a safe and effective amount of a conjugated linoleic acid (CLA) or a substance which is converted in the animal into CLA. A method of preparing CLA employing a bacteria isolated from a rat colon also is disclosed.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: October 27, 1998
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Mark E. Cook, Michael W. Pariza, Xiaoyun Yang, Danielle DeVoney
  • Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
    Patent number: 5674901
    Abstract: Methods of treating animals to maintain or elevate CD-4 and CD-8 cell levels and to prevent or alleviate the adverse effects on the animal caused by the production or exogenous administration of tumor necrosis factor (TNF) or by a virus consist of administering to the animal a safe and effective amount of a conjugated linoleic acid (CLA) or a substance which is converted in the animal into CLA. A method of preparing CLA employing a bacteria isolated from a rat colon also is disclosed.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: October 7, 1997
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Mark E. Cook, Michael W. Pariza, Xiaoyun Yang, Danielle DeVoney